Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiladitya Sengupta

Showing results (61-70 of 120) with videos related to

Pageof 12
Sort By:
Hepatology Communications|February 8, 2021
Human Nonalcoholic Steatohepatitis on a ChipMay S Freag, Bumseok Namgung, Maria E Reyna Fernandez, et al.
Oncotarget|September 23, 2016
Elevated level of acetylation of APE1 in tumor cells modulates DNA damage repairShiladitya Sengupta, Anil K Mantha, Heyu Song, et al.
Cellular Oncology (Dordrecht, Netherlands)|October 2, 2013
PEGylated liposomal Gemcitabine: insights into a potential breast cancer therapeuticAnne-Laure Papa, Almas Sidiqui, Sri Uma Aisvarya Balasubramanian, et al.
Nature Communications|February 12, 2015
Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transitionAaron Goldman, Biswanath Majumder, Andrew Dhawan, et al.
ACS Nano|June 4, 2016
Rationally Designed 2-in-1 Nanoparticles Can Overcome Adaptive Resistance in CancerAaron Goldman, Ashish Kulkarni, Mohammad Kohandel, et al.
Frontiers in Microbiology|October 5, 2020
Mechanistic Insight Into the Antifungal Effects of a Fatty Acid Derivative Against Drug-Resistant Fungal InfectionsAnamika Bhattacharyya, Mau Sinha, Himanshi Singh, et al.
Cancer Research|December 18, 2003
Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesisShiladitya Sengupta, Lynda A Sellers, Tereza Cindrova, et al.
Scientific Reports|June 10, 2016
Drug-induced reactive oxygen species (ROS) rely on cell membrane properties to exert anticancer effectsHamid R Molavian, Aaron Goldman, Colin J Phipps, et al.
Medical Oncology (Northwood, London, England)|April 10, 2013
P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancerSasmit Sarangi, Ambarish Pandey, Anne-Laure Papa, et al.
Dermatologic Therapy|July 19, 2016
Heterogeneity and antibiotic resistance in Propionibacterium acnes isolates and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypesSuresh Sadhasivam, Mau Sinha, Swamini Saini, et al.
Pageof 12

Showing results (61-70 of 120) with videos related to

Sort By:
Pageof 12
Hepatology Communications|February 8, 2021
Human Nonalcoholic Steatohepatitis on a ChipMay S Freag, Bumseok Namgung, Maria E Reyna Fernandez, et al.
Oncotarget|September 23, 2016
Elevated level of acetylation of APE1 in tumor cells modulates DNA damage repairShiladitya Sengupta, Anil K Mantha, Heyu Song, et al.
Cellular Oncology (Dordrecht, Netherlands)|October 2, 2013
PEGylated liposomal Gemcitabine: insights into a potential breast cancer therapeuticAnne-Laure Papa, Almas Sidiqui, Sri Uma Aisvarya Balasubramanian, et al.
Nature Communications|February 12, 2015
Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transitionAaron Goldman, Biswanath Majumder, Andrew Dhawan, et al.
ACS Nano|June 4, 2016
Rationally Designed 2-in-1 Nanoparticles Can Overcome Adaptive Resistance in CancerAaron Goldman, Ashish Kulkarni, Mohammad Kohandel, et al.
Frontiers in Microbiology|October 5, 2020
Mechanistic Insight Into the Antifungal Effects of a Fatty Acid Derivative Against Drug-Resistant Fungal InfectionsAnamika Bhattacharyya, Mau Sinha, Himanshi Singh, et al.
Cancer Research|December 18, 2003
Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesisShiladitya Sengupta, Lynda A Sellers, Tereza Cindrova, et al.
Scientific Reports|June 10, 2016
Drug-induced reactive oxygen species (ROS) rely on cell membrane properties to exert anticancer effectsHamid R Molavian, Aaron Goldman, Colin J Phipps, et al.
Medical Oncology (Northwood, London, England)|April 10, 2013
P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancerSasmit Sarangi, Ambarish Pandey, Anne-Laure Papa, et al.
Dermatologic Therapy|July 19, 2016
Heterogeneity and antibiotic resistance in Propionibacterium acnes isolates and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypesSuresh Sadhasivam, Mau Sinha, Swamini Saini, et al.
Pageof 12